MedTrace Logo

the Cogmed Program for Youths With ADHD

NCT03335748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-11-08

No results posted yet for this study

Summary

The primary objective of this study was to examine the effects of the Cogmed training program on working memory among youths 7 to 13 years old, while controlling presence and presentation of ADHD-related comorbidity. A secondary objective was to examine the generalization of effects to ADHD symptoms, non-verbal reasoning, attentional and executive functions, motor impulsivity, reading comprehension, and mathematical reasoning. Participants were under pharmacological treatment for ADHD combined type and a comorbidity. They were randomized into an experimental group that received the Cogmed program and an active control group that received a low-intensity comparison version of the training. They were evaluated at three time points: six weeks prior to intervention onset (T1), immediately prior to onset(T2), and one week following intervention completion (T3).

Conditions

  • ADHD
  • ADHD - Combined Type

Interventions

OTHER

Cognitive training Cogmed program

Cognitive training Cogmed program

Sponsors & Collaborators

  • Université de Montréal

    collaborator OTHER

  • Université de Sherbrooke

    collaborator OTHER

  • Paris West University Nanterre La Défense

    collaborator OTHER

  • Université du Québec a Montréal

    lead OTHER

Principal Investigators

  • Marie-claude Guay, Pr · Université du Quebec at Montréal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-22
Primary Completion
2014-09-22
Completion
2015-09-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335748 on ClinicalTrials.gov